Cardio3 BioSciences SA of Belgium said that its previously announced initial public offering of shares will commence on 21 June and end on 3 July. The indicative price range of the shares is between €16.65 per share and €19.00 per share. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
